Breast cancer screening aims to detect breast cancer in healthy women before symptoms appear, assuming early detection leads to better outcomes. Various screening methods are used, such as clinical and self breast exams, mammography, genetic screening, ultrasound, and MRI.
In 1988, the UK launched the world's first national breast cancer screening program, the NHS Breast Screening Programme, which achieved national coverage by the mid-1990s.
Starting in 1998, Medicare began covering annual screening mammography for women aged 40 and older.
In 2002, Singapore initiated its national breast screening program, BreastScreen Singapore, targeting women aged 50-64 for screening every two years. This program stands out as Asia's only publicly funded national breast cancer screening initiative.
In 2003, Canadian breast cancer screening programs varied in their offerings of clinical breast examinations and mammography screening for different age groups. Approximately 61% of women aged 50-69 reported having a mammogram within the past two years.
In 2003, a Cochrane review found that breast self-examination was not associated with lower death rates and increased harms due to the identification of benign lesions and unnecessary biopsies.
In 2005, approximately 68% of U.S. women aged 40-64 had undergone a mammogram in the preceding two years, with varying coverage based on insurance status.
As of 2006, roughly 76% of women aged 53–64 in England had received at least one breast cancer screening in the previous three years.
In 2009, the United States Preventive Services Task Force recommended that women over 50 should undergo mammography screening every two years.
In 2012, the Nordic Cochrane Collection suggested that advancements in diagnosis and treatment might reduce the effectiveness of mammography screening. They concluded that screening might no longer be effective in preventing deaths and raised concerns about misleading information online.
A 2013 Cochrane review estimated that mammography screening for women aged 50-75 resulted in a relative decrease in breast cancer death risk of 15%. However, the analysis of least biased trials showed no significant difference in mortality between screened and unscreened groups.
In 2013, the Cochrane Collaboration stated that the highest quality evidence did not show a decrease in cancer-specific or all-cause mortality due to mammography screening. They highlighted a 30% increase in overdiagnosis and overtreatment, raising questions about the balance of benefits and harms.
A 2016 UK study revealed lower breast cancer screening uptake among women with severe mental illness and those from minority ethnic communities, particularly women of South Asian heritage.
In 2017, the NHS Breast Screening Programme supported a research trial to assess the risks and benefits of screening for women aged 47-49 and 71-73.
In March 2022, the European Commission's Scientific Advice Mechanism suggested extending breast cancer screening to women in their mid-40s.
20 hours ago Hurricane Nolo Strengthens Near Hawaii Prompting Severe Flooding and High Wind Alerts
5 hours ago American Idol 2027 Judges Revealed Amid Lionel Richie Health Updates
5 hours ago Legendary Swimming Coach Frank Busch Passes Away at 75
5 hours ago Deadly Russian Drone Strikes Target Ukraine Amid Increasing Conflict Tensions
5 hours ago 2026 MLB Postseason Preview and World Series Championship Odds Analysis
6 hours ago Arthur Fils Faces Martin Damm in Tokyo ATP 500 Qualification Round
Jameis Winston is an American football quarterback currently playing for...
Ken Paxton is an American politician and lawyer serving as...
Shakira Isabel Mebarak Ripoll the Queen of Latin Music is...
Michael Joseph Jackson the King of Pop was a highly...
Sylvester Stallone is an iconic American actor screenwriter and filmmaker...
Dolly Parton is a celebrated American singer-songwriter actress philanthropist and...